Diaplex and Glycemic Control

Starting soon · Not applicable · Has a placebo group

Conditions studied: Insulin Sensitivity, Healthy Adult

In brief

The goal of this 16-week double-blind, placebo-controlled pilot study is to determine whether daily Diaplex supplementation improves insulin sensitivity and glycemic control in adults with elevated blood glucose levels, while generating high-quality preliminary data on metabolic effects, glycemic patterns, and safety to inform future trials

Key facts

Study ID

NCT07711587

Run by

Standard Process Inc.

People needed

40

Starts

2026-09-01

Expected to finish

2027-12-15

Last updated by the study team

2026-07-17

Who can join

Age: 30 and older, up to 65. Sex: any. Healthy volunteers: accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.